The Bioenergetic Health Index: a new concept in mitochondrial translational research

Bioenergetics has become central to our understanding of pathological mechanisms, the development of new therapeutic strategies and as a biomarker for disease progression in neurodegeneration, diabetes, cancer and cardiovascular disease. A key concept is that the mitochondrion can act as the ‘canary in the coal mine’ by serving as an early warning of bioenergetic crisis in patient populations. We propose that new clinical tests to monitor changes in bioenergetics in patient populations are needed to take advantage of the early and sensitive ability of bioenergetics to determine severity and progression in complex and multifactorial diseases. With the recent development of high-throughput assays to measure cellular energetic function in the small number of cells that can be isolated from human blood these clinical tests are now feasible. We have shown that the sequential addition of well-characterized inhibitors of oxidative phosphorylation allows a bioenergetic profile to be measured in cells isolated from normal or pathological samples. From these data we propose that a single value–the Bioenergetic Health Index (BHI)–can be calculated to represent the patient's composite mitochondrial profile for a selected cell type. In the present Hypothesis paper, we discuss how BHI could serve as a dynamic index of bioenergetic health and how it can be measured in platelets and leucocytes. We propose that, ultimately, BHI has the potential to be a new biomarker for assessing patient health with both prognostic and diagnostic value.

[1]  S. Ballinger,et al.  Effect of alcohol and tobacco smoke on mtDNA damage and atherogenesis. , 2007, Free radical biology & medicine.

[2]  H. Reuter,et al.  Platelet metabolism. , 1978, Supplementum ... ad Thrombosis and haemostasis.

[3]  V. Darley-Usmar,et al.  Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species. , 2010, Free radical biology & medicine.

[4]  J. Rathmell,et al.  Activated lymphocytes as a metabolic model for carcinogenesis , 2013, Cancer & Metabolism.

[5]  N. Larsson,et al.  Mitochondrial DNA mutations in disease and aging , 2011, The Journal of cell biology.

[6]  A. Landar,et al.  Nitric oxide and hypoxia exacerbate alcohol-induced mitochondrial dysfunction in hepatocytes. , 2011, Biochimica et biophysica acta.

[7]  J. Parks,et al.  Mitochondrial abnormalities in non-alcoholic steatohepatitis. , 1999, Journal of hepatology.

[8]  G. V. D. van der Windt,et al.  Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. , 2012, Immunity.

[9]  Philip A. Kramer,et al.  Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood , 2013, Laboratory Investigation.

[10]  Derin Tugal,et al.  Transcriptional control of macrophage polarization. , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[11]  A. Landar,et al.  Assessing bioenergetic function in response to oxidative stress by metabolic profiling. , 2011, Free radical biology & medicine.

[12]  Jianhua Zhang,et al.  Inhibition of autophagy and glycolysis by nitric oxide during hypoxia-reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons. , 2013, Free radical biology & medicine.

[13]  S. Ballinger,et al.  Developmental Exposure to Second-Hand Smoke Increases Adult Atherogenesis and Alters Mitochondrial DNA Copy Number and Deletions in apoE−/− Mice , 2013, PloS one.

[14]  S. Shiva,et al.  Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease. , 2013, Biochemical Society transactions.

[15]  Kamil Ugurbil,et al.  Oxidative capacity in failing hearts. , 2003, American journal of physiology. Heart and circulatory physiology.

[16]  D. Weihrauch,et al.  Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes. , 2010, Translational research : the journal of laboratory and clinical medicine.

[17]  N. Lévy,et al.  HIV-1 Infection and First Line ART Induced Differential Responses in Mitochondria from Blood Lymphocytes and Monocytes: The ANRS EP45 “Aging” Study , 2012, PloS one.

[18]  G. V. D. Windt,et al.  Metabolic switching and fuel choice during T‐cell differentiation and memory development , 2012, Immunological reviews.

[19]  G. Medina-Gómez Mitochondria and endocrine function of adipose tissue. , 2012, Best practice & research. Clinical endocrinology & metabolism.

[20]  N. Fineberg,et al.  Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells , 2013, Autophagy.

[21]  Ge Wang which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Fractal MapReduce decomposition of sequence alignment , 2005 .

[22]  E. Pearce,et al.  Metabolic pathways in immune cell activation and quiescence. , 2013, Immunity.

[23]  Reto Asmis,et al.  Bioenergetic Profiles Diverge During Macrophage Polarization: Implications for the Interpretation of 18F-FDG PET Imaging of Atherosclerosis , 2013, The Journal of Nuclear Medicine.

[24]  F. Bozza,et al.  Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5′-triphosphate synthase activity* , 2011, Critical care medicine.

[25]  N. Fineberg,et al.  Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress. , 2011, Free radical biology & medicine.

[26]  D. Wallace,et al.  Bioenergetic origins of complexity and disease. , 2011, Cold Spring Harbor symposia on quantitative biology.

[27]  J. Chatham,et al.  Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal. , 2009, The Biochemical journal.

[28]  S. Tabrizi,et al.  Mitochondria in the etiology and pathogenesis of parkinson's disease , 1998, Annals of neurology.

[29]  A. From,et al.  31P NMR measurement of mitochondrial uncoupling in isolated rat hearts. , 1990, The Journal of biological chemistry.

[30]  Ashok Balasubramanyam,et al.  The Role of the Immune System in Obesity and Insulin Resistance , 2013, Journal of obesity.

[31]  Min Wu,et al.  Bioenergetic profile experiment using C2C12 myoblast cells. , 2010, Journal of visualized experiments : JoVE.

[32]  J. Lancaster,et al.  Integration of cellular bioenergetics with mitochondrial quality control and autophagy , 2012, Biological chemistry.

[33]  S. Boudina,et al.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies. , 2013, Current pharmaceutical design.

[34]  Steven P Jones,et al.  Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. , 2011, Chemico-biological interactions.

[35]  L. Lind,et al.  Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality : prospective , population based cohort study , 2006 .

[36]  J. Keijer,et al.  Peripheral blood mononuclear cells as a model to study the response of energy homeostasis-related genes to acute changes in feeding conditions. , 2010, Omics : a journal of integrative biology.

[37]  Thomas A. Wynn,et al.  Macrophage biology in development, homeostasis and disease , 2013, Nature.

[38]  J. Bogner,et al.  Mitochondrial membrane potential and apoptosis of blood mononuclear cells in untreated HIV‐1 infected patients , 2009, HIV medicine.

[39]  M. Brand,et al.  Assessing mitochondrial dysfunction in cells , 2011, The Biochemical journal.

[40]  M. Murphy,et al.  Targeting lipophilic cations to mitochondria. , 2008, Biochimica et biophysica acta.

[41]  A. Aponte,et al.  Platelet Mitochondrial Dysfunction is Evident in Type 2 Diabetes in Association with Modifications of Mitochondrial Anti-Oxidant Stress Proteins , 2011, Experimental and Clinical Endocrinology & Diabetes (Barth).

[42]  Jun Li,et al.  Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. , 2014, Cellular signalling.

[43]  Jianhua Zhang,et al.  Distinct Effects of Rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on Cellular Bioenergetics and Cell Death , 2012, PloS one.

[44]  S. Ballinger,et al.  Mitochondrial genetics and obesity: evolutionary adaptation and contemporary disease susceptibility. , 2013, Free radical biology & medicine.

[45]  M. Gerschenson,et al.  Mitochondrial oxidative phosphorylation protein levels in peripheral blood mononuclear cells correlate with levels in subcutaneous adipose tissue within samples differing by HIV and lipoatrophy status. , 2008, AIDS research and human retroviruses.

[46]  I. Trounce,et al.  Mitochondrial dysfunction and complications associated with diabetes. , 2014, Biochimica et biophysica acta.

[47]  Chih-Hao Chang,et al.  Fueling Immunity: Insights into Metabolism and Lymphocyte Function , 2013, Science.

[48]  S. Krauss,et al.  Signaling takes a breath--new quantitative perspectives on bioenergetics and signal transduction. , 2001, Immunity.

[49]  S. Ballinger,et al.  The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics , 2011, Laboratory Investigation.

[50]  H. Smeets,et al.  Patients with Leber hereditary optic neuropathy fail to compensate impaired oxidative phosphorylation. , 2010, Biochimica et biophysica acta.